Shares of Moderna are trading lower Monday morning, taking a breather following a multi-day surge driven by clinical trial success.

Moderna stock catches the eye of investors looking for the next big AI play.

Shares of Moderna are trading lower Monday morning, taking a breather following a multi-day surge driven by clinical trial success.